Oramed Pharmaceuticals (ORMP) EPS (Weighted Average and Diluted) Growth (1y) (2023 - 2026)
Oramed Pharmaceuticals (ORMP) EPS (Weighted Average and Diluted) Growth (1y) (2023 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
251.11% |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
-13.31% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
102.51% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
-79.34% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
-103.05% |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
61.45% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Oramed Pharmaceuticals |
151.47 Mn |
133.31 Mn |
- |
578.95% |
| Date | Value |
|---|
| Mar 31, 2026 |
578.95% |
| Dec 31, 2025 |
192.31% |
| Sep 30, 2025 |
335.42% |
| Jun 30, 2025 |
40.91% |
| Mar 31, 2025 |
-575.00% |
| Dec 31, 2024 |
-178.79% |
| Sep 30, 2024 |
-500.00% |
| Jun 30, 2024 |
833.33% |
| Mar 31, 2024 |
150.00% |
| Dec 31, 2023 |
210.30% |
| Sep 30, 2023 |
55.69% |
| Jun 30, 2023 |
88.95% |
| Mar 31, 2023 |
70.32% |
